Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

Annals of Oncology

Volumn 7, Issue 1, 1996, Pages 95-98

  Machover, D ^a   Diaz Rubio, E ^b   De Gramont, A ^c   Schlif, A ^a   Gastiaburu, J J ^a,d   Brienza, S ^a,d   Itzhaki, M ^a   Metzger, G ^a   N'Daw, D ^a   Vignoud, J ^d   Abad, A ^e   Francois E ^f   Gamelin, E ^g   Marty, M ^h   Sastre, J ^b   Seitz, J F ⁱ   Ychou, M ^j  

^a HÔPITAL PAUL BROUSSE   (France)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HÔPITAL SAINT ANTOINE   (France)

^d DEBIOPHARM SA   (Switzerland)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f CENTRE ANTOINE LACASSAGNE   (France)

^g CENTRE PAUL PAPIN   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ INSTITUT PAOLI CALMETTES   (France)

^j CENTRE VAL D AURELLE   (France)

more..

Author keywords

Advanced colorectal carcinoma; Oxaliplatin; Phase II study

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0012797224     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010489     Document Type: Article

References (10)

1. Tashiro T, Kawada Y, Sakurai Y, Kidani Y. Antitumor activity of a new platinum complex, oxalato (trans-1-1,2-diaminocyclohexane) platinum (II): New experimental data. Biomed Pharmacother 1989; 43: 251-60.
2. Mathe G, Kidani Y, Segiguchi M et al. Oxalatoplatinum or L-OHP, a third-generation platinum complex: An experimental and clinical appraisal and preliminary comparison with cisplatinum and carboplatinum. Biomed Pharmacother 1989; 43: 237-50.
3. Pendyala L, Creaven PJ. In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Cancer Res 1993; 53: 5970-6.
4. Dorr RT. Von Hoff DD. Oxaliplatin. In Appleton and Lange (eds): Cancer Chemotherapy Handbook. Norwalk, CT 1993; 758-61.
5. Extra JM, Espie M, Calvo F et al. Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol 1990; 25: 299-303.
6. Levi F, Misset J-L, Brienza S et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Cancer 1992; 69: 893-900.
7. Desimone PA, Davila E, Jochimsen PR, Bartolucci AA. High dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: A Southeastern Cancer Study Group trial. Cancer Treat Rep 1986; 70: 1229-30.
8. Lokich J, Zipoli T, Greene R et al. Protracted low-dose cisplatin infusion in advanced colorectal cancer. Cancer Treat Rep 1986; 70: 523-34.
9. Nole F, Biganzoli L. Buzzoni R, Bajetta E. Carboplatin in patients with advanced colorectal cancer pretreated with fluoropyrimidines. Eur J Cancer 1993; 29: 1330-1.
10. Diaz-Rubio E, Jimeno J, Anton A et al. A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.). Am J Clin Oncol 1992; 15: 56-60.